Autopsy report · NCT01733836
Prostate Cancer Active Surveillance Metformin Trial
Cause of deathOther
“The reason for this decision is that this study is being merged with a larger multi-centre study using the same agent in the same population.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- University Health Network, Toronto
- Sponsor type
- University, hospital or other
- Conditions
- Prostate Cancer
- Interventions
- Metformin; placebo
- Participants
- 0
- Sites
- 1
- Countries
- Canada
Trials that died the same way
- Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes
“study merged with another study” - Use of Magnetic Imaging to Asses the Efficacy of Cap Assisted Colonoscopy in Reducing Looping and Improving Patient Acceptance for the Colonoscopy Procedure
“The study was incorporated in another study.” - NIRS as a Continuous Noninvasive Monitoring System of Liver/Kidney Graft Perfusion
“due to a decision by the research team not to continuos the study” - Central Glutathione Levels in Women With Late Life Depression: a Cross Sectional Pilot Feasibility Study
“A larger study collecting the same outcomes is currently being conducted by the study team.” - Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia
“Due to Competing Studies”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.